Ten epidemics of plague are known to have occurred in Bergen, Norway, from the Black Death in 1349 to the last epidemic in 1637. Seven of them took place after 1530, and the primary sources of only three are known from the first 180 years of the plague period. Therefore, additional epidemics have probably occurred of which we have no knowledge. After the Black Death, bubonic plague probably hit Bergen, and the infection seems to have always been imported by ships, especially ships from Baltic cities. During the last five epidemics in Bergen 12,900-14,500 people died on plague in the course of 70 years, i.e. twice the population of the city. Extended immigration following each epidemic kept the size of the population up to 6,000-7,000. The death rate was clearly lower among the Germans at the Hanseatic Office than in the Norwegian city population. This was probably because an increasing percentage of Germans had become immune to plague after each epidemic, since the losses at the Office were not compensated for by immigration. It is concluded that the plague epidemics are the main reason for the population crises in Bergen in this period.
Download full-text PDF |
Source |
---|
Acta Obstet Gynecol Scand
January 2025
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Introduction: More women with congenital heart disease (CHD) are pursuing pregnancy. Their cardiac condition may impact the pregnancy and necessitate interventions during childbirth. We aimed to investigate labor onset and delivery mode in women with CHD relative to women without heart disease and explore the time trends of induced labor and cesarean deliveries.
View Article and Find Full Text PDFFront Immunol
January 2025
Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
Objectives: Juvenile idiopathic arthritis (JIA) originates from a complex interplay between genetic and environmental factors. We investigated the association between seafood intake and dietary contaminant exposure during pregnancy and JIA risk, to identify sex differences and gene-environment interactions.
Methods: We used the Norwegian Mother, Father, and Child Cohort Study (MoBa), a population-based prospective pregnancy cohort (1999-2008).
Cancer Manag Res
January 2025
Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, Norway.
Purpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. The objective of this study was to describe the survival of real-world patients with metastatic RCC (mRCC) across Norway and to identify associated factors. The results may provide additional information on the benefits of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) in clinical practice.
View Article and Find Full Text PDFActa Oncol
January 2025
Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Background And Purpose: In the late 1990s, the Nordic countries, with Norway at the top, were among the countries with the highest prostate cancer mortality in the world. We present updated mortality rates from the Nordic countries and discuss possible interpretations of changes in trends.
Material And Methods: Age-standardized rates for prostate-specific mortality in 1985-2022, estimated lifetime risk of death (0-84 years) and annual changes in mortality were obtained from the NORDCAN database.
BMC Neurol
January 2025
Department for Physical Health and Aging, Norwegian Institute of Public Health, Oslo, Norway.
Background: Childlessness, as well as having a high number of children, has been reported to be associated with an elevated risk of dementia compared to having 2-3 children. The mechanisms underlying these relationships are not well understood and may be mediated by different midlife risk factors. We examined the mediating role of various factors on the relationship between the number of children and dementia risk.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!